PRS launches Global Regulatory Intelligence Database

Pharmaceutical Regulatory Services, Inc. (PRS Inc.), a global provider of regulatory and pharmacovigilance support to the pharmaceutical, biotechnology and medical device industries, is pleased to announce the launch of GRID™ - Global Regulatory Intelligence Database. In line with our mission to offer our customers the most up-to-date global regulatory and pharmacovigilance support services we now offer an online database of pre-approval and post-approval pharmacovigilance requirements for drugs and biologics in over 75 countries on all continents. The GRID™ provides an online reference resource with original national legislative documents for more in-depth analysis when needed.

Available on cloud technology platform, the database has been developed and is maintained by the PRS pharmacovigilance experts. The GRID™ database includes information in an easy-to-find grid format with hyperlinks to the most current reference documents. While the database is maintained by PRS, clients have the capability to include their own comments into a client specific comment section.

PRS safety experts search and collect applicable documentation. After reviewed and analyzed information is entered into the GRID™, E-mail alert notifications are sent to our clients, including the summary of the new information in English with links to the original referenced documents. The GRID database is updated daily and the clients' pharmacovigilance personnel can access the updated information 24/7, 365 days a year.

Access to this database's innovative technology and daily updates of changes in global pharmacovigilance requirements saves our customers significant internal resources while ensuring all their pharmacovigilance responsibilities can be met. The expansion of GRID capabilities will continue to be a strategic focus for PRS in the future.

Source: Pharmaceutical Regulatory Services, Inc.